A. Thadi, W.F. Morano, M. Khalili, B.B. Babcock, M.F. Shaikh, D.S. Foster, Y. Piazza, E.M. Gleeson, E. Goldstein, L. Steele, P.M. Campbell, B. Lin, M.R. Pincus, W.B. Bowne. 2021. Molecular targeting of H/MDM-2 oncoprotein in human colon cancer cells and stem-like colonic epithelial derived progenitor cells. Anticancer Res, 41:27-42. Pubmed.
Sliker B.H. and Campbell P.M. 2020. Ras and Ras Signaling as a therapeutic target in cancer. In Comprehensive Pharmacology, Terry Kenakin, Ph.D., editor, in press.
A. Thadi, E.M. Gleeson, M. Khalili, M.F. Shaikh, E. Goldstein, W.F. Morano, L.M. Daniels, N. Grandhi, H. Glatthorn, S.D. Richard, P.M. Campbell, M.R. Pincus, W.B. Bowne. 2020. Anti-cancer tumor cell necrosis of multidrug resistant ovarian cancer cell lines depends on high expression of HDM-2 protein in their membranes. Ann Clin Lab Sci, 50:611-624. Pubmed
A. Thadi, L. Lewis, E. Goldstein, A. Aggarwal, M. Khalili, L. Steele, B. Polyak, S. Seydafkan, M.H. Bluth, K.A. Ward, M. Styler, P.M. Campbell, M.R. Pincus, W.B. Bowne. 2020. Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells but Not Normal Hematopoietic Cells. Anticancer Res, 40:4857-4867. Pubmed
M.C. Stout and P.M. Campbell. 2018. RASpecting the oncogene: New pathways to therapeutic advances. Biochem Pharm, 158: 217-228. Pubmed
M.C. Stout, S. Narayan, E.S. Pillet, J.S. Salvino, P.M. Campbell. 2018. Inhibition of CX3CR1 Reduces Cell Motility and Viability in Pancreatic Adenocarcinoma Epithelial Cells. Biochem Biophys Res Commun, 495:2264– 2269. PubMed
S. Lal*, E. Cheung*, M. Zarei*, R. Preet, S.N. Chand, N.C. Mambelli-Lisboa, C. Romeo, M.C. Stout, E. Londin, A. Goetz, C. Yabar, A. Nevler, C.J. Yeo, P.M. Campbell, J.M. Winter, D.A. Dixon, J.R. Brody. 2017. CRISPR knockout of the HuR gene in pancreatic and colorectal cancer cells causes a xenograft lethal phenotype. * Contributed equally. Mol Cancer Res, 15:696-707. PubMed
M.C. Stout, E. Asiimwe, J.R. Birkenstamm, S.Y. Kim, P.M. Campbell. 2014. Analyzing Ras-associated Cell Proliferation Signaling. Methods Mol Biol, 1170:393-409. PubMed
P.M. Campbell. 2014. Oncogenic Ras pushes (and pulls) cell cycle progression through ERK activation. Methods Mol Biol, 1170:155-163. PubMed
H.R. Siddique, D.J. Liao, S.K. Mishra, T. Schuster, L. Wang, B. Matter, P.M. Campbell, P. Villalta, S. Nanda, Y. Deng, M. Saleem. 2012. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model. Int J Cancer, 131:1720–1731. PubMed
J.J. Yeh, J.P. Madigan, P.M. Campbell, P.J. Roberts, L.M. DeGraffrenreid, C.J. Der. 2011. Targeting Ras for anti-cancer drug discovery. In Intercellular Signaling in Development and Disease, E.A. Dennis and R.A. Bradshaw, eds. Elsevier Press, pp. 335-355.
P.M. Campbell*, N. Boufaied*, J.J. Fiordalisi, A.D. Cox, P. Falardeau, C.J. Der, H. Gourdeau. 2010. TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-MAPK signaling. J Mol Signal, 5:18. * Contributed equally PubMed
Y. Matsuo*, P.M. Campbell*, R.A. Brekken, B. Sung, M.M. Ouellette, J.B. Fleming, B.B. Aggarwal, C.J. Der, S. Guha. 2009. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through MAP kinase signaling pathways. Mol Cancer Res, 7:799-808. * Contributed equally. PubMed
P.M. Campbell, K.M. Lee, M.M. Ouellette, H.J. Kim, A.L. Groehler, V. Khazak, C.J. Der. 2008. Ras-driven transformation of human nestin-positive pancreatic epithelial cells. Methods Enzymol 439:451-65. PubMed
P.M. Campbell, A.L. Groehler, K.M. Lee, M.M. Ouellette, V. Khazak, C.J. Der. 2007. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 67:2098-2106. PubMed